Non small cell lung cancer; Pulmonary function; Stereotactic body radiotherapy
Indexed keywords
CHRONIC OBSTRUCTIVE PULMONARY DISEASE;
COMPUTED TOMOGRAPHY;
LUNG CANCER;
MEDICAL CONDITIONS;
NON SMALL CELL LUNG CANCER;
POST TREATMENT;
PRE-TREATMENT;
PULMONARY FUNCTION;
PULMONARY FUNCTION TEST;
STEREOTACTIC BODY RADIOTHERAPY;
SURGICAL RESECTION;
TUMOR VOLUMES;
Stereotactic single-dose radiotherapy of stage i non-small-cell lung cancer (NSCLC)
H. Hof, K.K. Herfarth, and M. Munter Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC) Int J Radiat Oncol Biol Phys 56 2003 335 341
Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
Y. Nagata, K. Takayama, and Y. Matsuo Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame Int J Radiat Oncol Biol Phys 63 2005 1427 1431
Results of a phase i dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors
Q.T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
The North American experience with stereotactic body radiation therapy in non-small cell lung cancer
R.D. Timmerman, C. Park, and B.D. Kavanagh The North American experience with stereotactic body radiation therapy in non-small cell lung cancer J Thorac Oncol 2 2007 S101 S112
Stereotactic body radiotherapy for medically inoperable patients with stage i non-small cell lung cancer: A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
P. Baumann, J. Nyman, and M. Hoyer Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer: A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study Radiother Oncol 88 2008 359 367
Outcome in a prospective phase II trial of medically inoperable stage i non-small-cell lung cancer patients treated with stereotactic body radiotherapy
P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination
T. Inoue, S. Shimizu, O. Rikiya, and A. Takeda Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination Int J Radiat Oncol Biol Phys 75 2009 683 687
J Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage i lung cancer in medically inoperable patients
K.L. Stephans, T. Djemil, and C. Reddy J Comprehensive analysis of pulmonary function test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients Thorac Oncol 4 2009 838 844
Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage 1 non-small-cell lung cancer
M. Henderson, R. McGarry, and C. Yiannoutsos Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage 1 non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 404 409
Differences in pulmonary function before vs 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors
T. Ohashi, A. Takeda, and N. Shigematsu differences in pulmonary function before vs 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors Int J Radiat Oncol Biol Phys 62 2005 1003 1008